European Journal of Internal Medicine · 2024 · 26 citations · 26 references
Life SciencesCardiologyImmunologyImmunopathologyInflammationInnate ImmunityCardiovascular DiseaseCholesterol MetabolismFamilial HypercholesterolemiaLipid MetabolismLipoprotein MetabolismMetabolic InflammationAtherosclerosis GeneticsAtherosclerosis RiskAtherosclerotic Risk AssessmentAtherosclerotic Risk In Lipid DisordersLipid Profile AnalysisPlasma Cholesterol LevelsSubclinical Atherosclerosis
BACKGROUND: Familial hypercholesterolemia (FH) is a genetic condition characterized by high low-density lipoprotein cholesterol (LDL-C). The presence of risk modifiers could promote the atherosclerotic injury beyond LDL-C. Our aim was to evaluate metabolic and innate immunity profiles in FH subjects with or without subclinical atherosclerosis. METHODS: In this cross-sectional observational study, we evaluated 211 genetically confirmed FH subjects on LDL-C target and without cardiovascular diseases. Biochemical analyses, LDL-C burden (LCB) calculation and vascular profile evaluation were obtained from all subjects. Study population was divided into two groups according to subclinical atherosclerosis: the subclinical atherosclerosis (SA) group and non-subclinical atherosclerosis (NSA) group. RESULTS: SA group had higher LDL-C at diagnosis (288.35 ± 24.52 vs 267.92 ± 23.86, p < 0.05) and LCB (13,465.84 ± 3617.46 vs 10,872.63 ± 3594.7, p < 0.001) than NSA group. SA group had higher white blood cell count (WBCC, 6.9 ± 1.66 vs 6.1 ± 1.16), neutrophil count (NC, 4.2 ± 1.3 vs 3.6 ± 1.11), monocyte count (MC, 0.8 ± 0.2 vs 0.4 ± 0.1), triglyceride to high-density lipoprotein ratio (TG/HDL, 1.73 ± 0.72 vs 1.45 ± 0.69), triglyceride-glucose index (TyG, 8.29 ± 0.35 vs 8.01 ± 0.33) than NSA group (p value for all < 0.01). Multivariate logistic regression analysis showed that LCB (p < 0.01), WBCC (p < 0.01), NC (p < 0.05), MC (p < 0.05) were associated with subclinical atherosclerosis. Simple linear regression analyses showed that LCB was associated with WBCC, NC, MC (p value for all < 0.01). CONCLUSION: An increased LCB and an impaired innate immunity profile were found in FH subjects with subclinical atherosclerosis and they were independently associated with atherosclerotic injury. LCB could modulate the innate immunity profile.
26
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders et al. · European Heart Journal · 2021 · 6.3K citations · Full text
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean‐Claude Tardif, Simon Kouz, David D. Waters et al. · New England Journal of Medicine · 2019 · 3K citations · Full text
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf, Aernoud T.L. Fiolet, Arend Mosterd et al. · New England Journal of Medicine · 2020 · 2.1K citations · Full text
Medicine, Cardiology, Pharmacology +15
Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis
Maik Drechsler, Remco T. A. Megens, Marc van Zandvoort et al. · Circulation · 2010 · 698 citations · Full text
Life Sciences, Immunology, Pathology +16